Morris Jessop, MD
Urology · Great Falls, MTNPI 1043655046
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (32.7%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 66.4% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2023 at $8,429 and has fallen 98.2% since, to $154 in 2025. Among urology clinicians in MT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 65 payments — averaging $189.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$8K
- Neotract Inc.$2K
- Boston Scientific$1K
- AbbVie$242
- Teleflex LLC$143
- Johnson & Johnson$104
- plus $567 from 14 others
What the payments were for
- Speaking & faculty fees$4,00032%
- Travel & lodging$2,47420%
- Food & beverage$1,81915%
- Education$4,02733%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 4 | $8,183 |
| Neotract Inc. | 3 | $1,664 |
| Boston Scientific | 11 | $1,417 |
| AbbVie(2 entities) | 11 | $242 |
| Teleflex LLC | 2 | $143 |
| Johnson & Johnson(2 entities) | 6 | $104 |
| Pacira Pharmaceuticals Incorporated | 1 | $93 |
| Sumitomo Pharma America, Inc. | 4 | $79 |
| Myriad Genetic Laboratories, Inc. | 5 | $71 |
| 180 Medical, Inc. | 2 | $59 |
| Photocure Inc | 2 | $51 |
| Conmed Corporation | 2 | $48 |
| Myovant Sciences Inc. | 2 | $37 |
| Astellas Pharma US Inc | 2 | $33 |
| Axonics, Inc. | 1 | $29 |
| Novartis | 1 | $17 |
| Urogen Pharma, Inc. | 1 | $14 |
| Sanofi Pasteur Inc. | 1 | $13 |
| KARL Storz Endoscopy-america | 1 | $13 |
| Travere Therapeutics, Inc. | 3 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$4,150
- DA VINCI SP$4,000
- UroLift$1,664
- SPACEOAR$1,013
- UroLift System$107
How this compares
$12,320 in reported general payments places this provider in the 95th percentile of 45 urology providers in Montana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 89 | $63,288 |
| PremarinEstrogens, Conjugated | 16 | $6,995 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 53 | $2,562 |
| Oxybutynin Chloride ErOxybutynin Chloride | 97 | $2,236 |
| Tamsulosin Hcl | 105 | $1,130 |
| Testosterone | 12 | $959 |
| Cephalexin | 62 | $525 |
| Solifenacin Succinate | 38 | $476 |
| Finasteride | 33 | $343 |
| Oxybutynin Chloride | 17 | $319 |
| Ciprofloxacin Hcl | 66 | $207 |
| NitrofurantoinNitrofurantoin Macrocrystal | 13 | $169 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 65 | $143 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 53 | $122 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $33 | $63,28889 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 45 urology providers in Montana.
Other urology in Great Falls
- Christopher FukudaGreat Falls$19K
- Connor McCormickGreat Falls$4K
- Brian MalloyGreat Falls$1K
- Richard SlaterGreat Falls$1K
- David GuthGreat Falls$400
- Rollin BearssGreat Falls$361
- George SealGreat Falls$21
- Garrick SimmonsMissoula$16K
- Jason SkenazyBozeman$12K
- Amy McKerrowKalispell$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.